142 related articles for article (PubMed ID: 37540951)
1. New Schiff bases derived from dimethylpyridine-1,2,4-triazole hybrid as cytotoxic agents targeting gastrointestinal cancers: Design, synthesis, biological evaluation and molecular docking studies.
Strzelecka M; Wiatrak B; Jawień P; Czyżnikowska Ż; Świątek P
Bioorg Chem; 2023 Oct; 139():106758. PubMed ID: 37540951
[TBL] [Abstract][Full Text] [Related]
2. New Oxazolo[5,4-
Sochacka-Ćwikła A; Mączyński M; Czyżnikowska Ż; Wiatrak B; Jęśkowiak I; Czerski A; Regiec A
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232997
[TBL] [Abstract][Full Text] [Related]
3. 1,2,3-triazole and chiral Schiff base hybrids as potential anticancer agents: DFT, molecular docking and ADME studies.
Belay Y; Muller A; Mokoena FS; Adeyinka AS; Motadi LR; Oyebamiji AK
Sci Rep; 2024 Mar; 14(1):6951. PubMed ID: 38521876
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity and Antibacterial Evaluation of O-Alkylated/Acylated Quinazolin-4-one Schiff Bases.
Manhas N; Singh P; Mocktar C; Singh M; Koorbanally N
Chem Biodivers; 2021 May; 18(5):e2100096. PubMed ID: 33724670
[TBL] [Abstract][Full Text] [Related]
5. Halting Tumor Progression via Novel Non-Hydroxamate Triazole-Based Mannich Bases MMP-2/9 Inhibitors; Design, Microwave-Assisted Synthesis, and Biological Evaluation.
Albelwi FF; Teleb M; Abu-Serie MM; Moaty MNAA; Alsubaie MS; Zakaria MA; El Kilany Y; Aouad MR; Hagar M; Rezki N
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638665
[TBL] [Abstract][Full Text] [Related]
6. Hybrid Pharmacophore Design, Molecular Docking, Synthesis, and Biological Evaluation of Novel Aldimine-Type Schiff Base Derivatives as Tubulin Polymerization Inhibitor.
Ameri A; Khodarahmi G; Forootanfar H; Hassanzadeh F; Hakimelahi GH
Chem Biodivers; 2018 Mar; 15(3):e1700518. PubMed ID: 29292595
[TBL] [Abstract][Full Text] [Related]
7. Exploration of novel VEGFR2 tyrosine kinase inhibitors via design and synthesis of new alkylated indolyl-triazole Schiff bases for targeting breast cancer.
Nafie MS; Boraei ATA
Bioorg Chem; 2022 May; 122():105708. PubMed ID: 35290929
[TBL] [Abstract][Full Text] [Related]
8.
Yusof ENM; Latif MAM; Tahir MIM; Sakoff JA; Simone MI; Page AJ; Veerakumarasivam A; Tiekink ERT; Ravoof TBSA
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30781445
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization, and biological properties of novel Schiff bases containing pentafluorophenyl hydrazine.
Hamurcu F
J Biochem Mol Toxicol; 2023 Dec; 37(12):e23512. PubMed ID: 37638565
[TBL] [Abstract][Full Text] [Related]
10. Discovery of New Schiff Bases Tethered Pyrazole Moiety: Design, Synthesis, Biological Evaluation, and Molecular Docking Study as Dual Targeting DHFR/DNA Gyrase Inhibitors with Immunomodulatory Activity.
Hassan AS; Askar AA; Naglah AM; Almehizia AA; Ragab A
Molecules; 2020 Jun; 25(11):. PubMed ID: 32498469
[TBL] [Abstract][Full Text] [Related]
11. In Silico Approach Using Free Software to Optimize the Antiproliferative Activity and Predict the Potential Mechanism of Action of Pyrrolizine-Based Schiff Bases.
Almalki FA; Abdalla AN; Shawky AM; El Hassab MA; Gouda AM
Molecules; 2021 Jun; 26(13):. PubMed ID: 34209011
[TBL] [Abstract][Full Text] [Related]
12. New Indazol-Pyrimidine-Based Derivatives as Selective Anticancer Agents: Design, Synthesis, and In Silico Studies.
Al-Tuwaijri HM; Al-Abdullah ES; El-Rashedy AA; Ansari SA; Almomen A; Alshibl HM; Haiba ME; Alkahtani HM
Molecules; 2023 Apr; 28(9):. PubMed ID: 37175074
[TBL] [Abstract][Full Text] [Related]
13. A New Series of Triazolothiadiazines as Potential Anticancer Agents for Targeted Therapy of Non-Small Cell Lung and Colorectal Cancers: Design, Synthesis, In silico and In vitro Studies Providing Mechanistic Insight into Their Anticancer Potencies.
Sever B; Altıntop MD; Çiftçi GA; Özdemir A
Med Chem; 2021; 17(10):1104-1128. PubMed ID: 33087032
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis and Antiproliferative Evaluation of Novel 1,2,4-Triazole/Schiff Base Hybrids with EGFR and B-RAF Inhibitory Activities.
El-Sherief HAM; Youssif BGM; Abdelazeem AH; Abdel-Aziz M; Abdel-Rahman HM
Anticancer Agents Med Chem; 2019; 19(5):697-706. PubMed ID: 30582484
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, Anticancer Activity and Molecular Docking Studies of Novel
Strzelecka M; Glomb T; Drąg-Zalesińska M; Kulbacka J; Szewczyk A; Saczko J; Kasperkiewicz-Wasilewska P; Rembiałkowska N; Wojtkowiak K; Jezierska A; Świątek P
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232475
[TBL] [Abstract][Full Text] [Related]
16. Anticancer effects of seaweed compounds fucoxanthin and phloroglucinol, alone and in combination with 5-fluorouracil in colon cells.
Lopes-Costa E; Abreu M; Gargiulo D; Rocha E; Ramos AA
J Toxicol Environ Health A; 2017; 80(13-15):776-787. PubMed ID: 28850007
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, crystal structures, antiproliferative activities and reverse docking studies of eight novel Schiff bases derived from benzil.
Tan XJ; Wang D; Hei XM; Yang FC; Zhu YL; Xing DX; Ma JP
Acta Crystallogr C Struct Chem; 2020 Jan; 76(Pt 1):44-63. PubMed ID: 31919307
[TBL] [Abstract][Full Text] [Related]
18. Optimization of pyrrolizine-based Schiff bases with 4-thiazolidinone motif: Design, synthesis and investigation of cytotoxicity and anti-inflammatory potency.
Shawky AM; Abourehab MAS; Abdalla AN; Gouda AM
Eur J Med Chem; 2020 Jan; 185():111780. PubMed ID: 31655429
[TBL] [Abstract][Full Text] [Related]
19. Schiff Bases and their Metal Complexes as Potential Anticancer Candidates: A Review of Recent Works.
Tadele KT; Tsega TW
Anticancer Agents Med Chem; 2019; 19(15):1786-1795. PubMed ID: 30827264
[TBL] [Abstract][Full Text] [Related]
20. Benzoin Schiff Bases: Design, Synthesis, and Biological Evaluation as Potential Antitumor Agents.
Sabbah DA; Al-Tarawneh F; Talib WH; Sweidan K; Bardaweel SK; Al-Shalabi E; Zhong HA; Abu Sheikha G; Abu Khalaf R; Mubarak MS
Med Chem; 2018; 14(7):695-708. PubMed ID: 29651943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
